Amgen Inc. (AMGN) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Amgen Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.116 My name is Julianne and I will be your conference facilitator today for the Amgen Q3 00:00:04.116 -- 00:00:09.263 2025 earnings conference call. All lines have been placed on mute to prevent 00:00:09.263 -- 00:00:13.448 any background noise. There will be a question and answer session at the conclusion of 00:00:13.448 -- 00:00:17.774 the last speaker's prepared remarks. In order to ensure that everyone has a chance to 00:00:17.774 -- 00:00:21.078 participate, we would like to request that you limit yourself to asking one question 00:00:21.078 -- 00:00:25.885 during the Q&A session. To ask a question, please press star then the number one on your 00:00:25.885 -- 00:00:30.895 telephone keypad. To withdraw your question, please press star one again. 00:00:30.895 -- 00:00:35.079 I would now like to introduce Casey Caporelli, Vice President of Investor Relations. 00:00:35.079 -- 00:00:38.180 Mr. Caporelli, you may now begin. 00:00:39.042 -- 00:00:41.964 Thank you, Julianne, and good afternoon, everyone. 00:00:41.964 -- 00:00:45.648 Welcome to our third quarter 2025 earnings call. 00:00:45.648 -- 00:00:50.151 Bob Bradway will lead the call and be followed by a broader review of our performance 00:00:50.151 -- 00:00:54.795 by Peter Griffith, Murdo Gordon, and Jay Bratner. 00:00:54.795 -- 00:00:58.979 Through the course of our discussion today, we will use non-GAAP financial measures to 00:00:58.979 -- 00:01:03.952 describe our performance, and have provided appropriate reconciliations within the materials 00:01:03.952 -- 00:01:09.059 that accompany this call. We will also make some forward-looking statements, which 00:01:09.059 -- 00:01:13.765 are qualified by our safe harbor statement, and please note that actual results could 00:01:13.7...